Ribociclib 10 mg | 98.27%
TargetMol
LEE011 is an orally available, and highly specific CDK4/6 inhibitor (IC50：10/39 nM).
More Information Supplier PageRibociclib
Search Results
PP1 5 mg | 99.82%
TargetMol
PP1, a specific and effective Src inhibitor, is with IC50 for Lck/Fyn is 5 nM/ 6 nM, respectively.
More Information Supplier PagePP1
PP1 50 mg | 99.82%
TargetMol
PP1, a specific and effective Src inhibitor, is with IC50 for Lck/Fyn is 5 nM/ 6 nM, respectively.
More Information Supplier PagePP1
KU-57788 10 mg | 99.87%
TargetMol
NU7441 (KU-57788) is a highly effective and specific DNA-PK inhibitor (IC50: 14 nM).
More Information Supplier PageKU-57788
KU-57788 25 mg | 99.87%
TargetMol
NU7441 (KU-57788) is a highly effective and specific DNA-PK inhibitor (IC50: 14 nM).
More Information Supplier PageKU-57788
Besifloxacin Hydrochloride 100 mg | 99.95%
TargetMol
Besifloxacin Hydrochloride (BOL-303224-A) is a fourth-generation fluoroquinolone antibiotic.
More Information Supplier PageBesifloxacin Hydrochloride
Enzastaurin 5 mg | 98.52%
TargetMol
Enzastaurin (LY317615) is an effective PKCβ selective inhibitor (IC50: 6 nM), 6- to 20-fold selectivity against PKCα/γ/ε.
More Information Supplier PageEnzastaurin
Enzastaurin 50 mg | 98.52%
TargetMol
Enzastaurin (LY317615) is an effective PKCβ selective inhibitor (IC50: 6 nM), 6- to 20-fold selectivity against PKCα/γ/ε.
More Information Supplier PageEnzastaurin
Enzastaurin 25 mg | 98.52%
TargetMol
Enzastaurin (LY317615) is an effective PKCβ selective inhibitor (IC50: 6 nM), 6- to 20-fold selectivity against PKCα/γ/ε.
More Information Supplier PageEnzastaurin
Enzastaurin 10 mg | 98.52%
TargetMol
Enzastaurin (LY317615) is an effective PKCβ selective inhibitor (IC50: 6 nM), 6- to 20-fold selectivity against PKCα/γ/ε.
More Information Supplier PageEnzastaurin